CHGFCanadian Heritage Garden Foundation (Ottawa, Ontario, Canada)
References in periodicals archive ?
Baseline ctDNA, baseline cHGF, and ECOG performance status most strongly predicted overall survival, said the investigators.
Median overall survival for vemurafenib was shortest (7.3 months) in the subgroup of 64 patients with detectable BRAFV600 ctDNA and elevated cHGF, according to the researchers.
Differences in expression levels are expressed as change factors (CHGF), which report the change in expression (signal) between two experimental conditions (baseline = control and treated).